Status:
COMPLETED
Transplantation for Patients With Chronic Lymphocytic Leukemia
Lead Sponsor:
Stanford University
Conditions:
Leukemia, Lymphocytic, Chronic
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
Detailed Description
To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.
Eligibility Criteria
Inclusion
- adequate organ function
- normal bone marrow cytogenetics
Exclusion
- active CNS disease
- For autologous patients more than 30% bone marrow involvement
Key Trial Info
Start Date :
November 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00186303
Start Date
November 1 1996
End Date
March 1 2010
Last Update
December 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305